Your study provides valuable insights into BCNC-modified zirconomer. However, could you clarify the mechanism behind reduced mechanical performance at higher BCNC concentrations? Is agglomeration or uneven distribution a factor? Additionally, the significant discoloration at higher concentrations raises concerns about clinical use in visible areas. Lastly, how do you plan to address biocompatibility and validate these findings in vivo for long-term applications?